
NeurOp Receives FDA Orphan Drug Designation for NP10679 for Subarachnoid Hemorrhage Treatment
The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to NeurOp, Inc.'s investigational candidate NP10679 to treat Subarachnoid hemorrhage (SAH). NeurOp is working on a subun ...